Karp, Barbara Illowsky http://orcid.org/0000-0002-4604-0142
Tandon, Hannah
Vigil, Deionna
Stratton, Pamela
Funding for this research was provided by:
Division of Intramural Research, National Institutes of Health
Article History
Received: 24 August 2018
Accepted: 16 November 2018
First Online: 7 January 2019
Compliance with ethical standards
:
: The authors declare that they have no conflicts of interest related to this article.
: Dr Karp, Dr Stratton are investigators and Ms Tandon was a research assistant on a different study for which the National Institutes of Health received a grant from Allergan, Inc, the manufacturer of onabotulinumtoxinA (Botox). Dr Karp is also an associate investigator on one study for which the Icahn School of Medicine at Mt Sinai received a grant from Allergan, Inc, and another study for which the National Institutes of Health received a grant from Merz, Inc, the manufacturer of incobotulinumtoxinA (Xeomin). Ms Vigil has no disclosures.